Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022	$ 320,740	$ 42	$ 432,703	$ (1,535)	$ (110,470)
Beginning balance (in shares) at Dec. 31, 2022		41,616,260
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	56,530	$ 4	56,526
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		4,153,717
Exercise of pre-funded common stock warrants (in shares)		80,257
Exercise of common stock options	2,246		2,246
Exercise of common stock options (in shares)		253,545
Shares issued under employee stock purchase plan	772		772
Shares issued under employee stock purchase plan (in shares)		90,574
Vesting of restricted shares	149		149
Vesting of restricted shares (in shares)		58,087
Stock-based compensation	20,005		20,005
Unrealized gain on available-for-sale securities, net	2,200			2,200
Net loss	(58,293)				(58,293)
Ending balance at Dec. 31, 2023	344,349	$ 46	512,401	665	(168,763)
Ending balance (in shares) at Dec. 31, 2023		46,252,440
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	697,920	$ 12	697,908
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		11,548,094
Exercise of common stock options	$ 14,176	$ 1	14,175
Exercise of common stock options (in shares)	1,152,192	1,152,192
Issuance of common stock upon settlement of restricted stock units (in shares)		2,500
Shares issued under employee stock purchase plan	$ 792		792
Shares issued under employee stock purchase plan (in shares)		99,061
Vesting of restricted shares	20		20
Vesting of restricted shares (in shares)		10,319
Stock-based compensation	33,020		33,020
Unrealized gain on available-for-sale securities, net	1,498			1,498
Net loss	(68,994)				(68,994)
Ending balance at Dec. 31, 2024	1,022,781	$ 59	1,258,316	2,163	(237,757)
Ending balance (in shares) at Dec. 31, 2024		59,064,606
Exercise of pre-funded common stock warrants		$ 1	(1)
Exercise of pre-funded common stock warrants (in shares)		775,698
Exercise of common stock options	$ 4,070		4,070
Exercise of common stock options (in shares)	401,110	401,110
Issuance of common stock upon settlement of restricted stock units (in shares)		15,588
Shares issued under employee stock purchase plan	$ 1,222		1,222
Shares issued under employee stock purchase plan (in shares)		127,281
Stock-based compensation	40,221		40,221
Unrealized gain on available-for-sale securities, net	2,153			2,153
Net loss	(113,625)				(113,625)
Ending balance at Dec. 31, 2025	$ 956,822	$ 60	$ 1,303,828	$ 4,316	$ (351,382)
Ending balance (in shares) at Dec. 31, 2025		60,384,283